Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL222664 | 0.81 | LMNA (0.57) | LMNAHSD17B10ALOX15SERPINE1ALDH1A1 | |
| SCHEMBL6790179 | 0.81 | SERPINE1 (0.33) | LMNAHSD17B10SERPINE1ALDH1A1CTSK | |
| SCHEMBL14991075 | 0.80 | ALDH1A1 (0.46) | LMNAHSD17B10ALOX15SERPINE1ALDH1A1 | |
| SCHEMBL6790182 | 0.78 | ALDH1A1 (0.48) | LMNAHSD17B10SERPINE1ALDH1A1CTSK | |
| SCHEMBL4444268 | 0.78 | LMNA (0.34) | LMNAHSD17B10SERPINE1ALDH1A1CTSK | |
| SCHEMBL4444271 | 0.78 | LMNA (0.34) | LMNAHSD17B10SERPINE1ALDH1A1CTSK | |
| SCHEMBL30889142 | 0.77 | — | — | |
| SCHEMBL13686650 | 0.76 | PRKCA (0.39) | LMNAHSD17B10SERPINE1ALDH1A1CTSK | |
| SCHEMBL6721894 | 0.76 | SERPINE1 (0.33) | LMNAHSD17B10SERPINE1ALDH1A1CTSK | |
| SCHEMBL6789266 | 0.76 | NAAA (0.40) | LMNAHSD17B10SERPINE1ALDH1A1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024094637-A1 | PROCESS FOR THE PREPARATION OF CYCLIC KETONES | ARXADA AG (CH) | 2024-05-10 | — | — | WO | disclosed |